Augmented CAV1 expression has been associated previously with progression towards a more aggressive cancer phenotype, for instance for prostate cancer and melanomas [38, 68–70], although in those cases the precise mechanisms involved were not defined. This evidence concerns the gene CAV1 and cancer.